Elevated fetal haemoglobin is a predictor of better outcome in MDS/AML patients receiving 5-aza-2′-deoxycytidine (Decitabine)-Reference-Cited by-同舟云学术

Elevated fetal haemoglobin is a predictor of better outcome in MDS/AML patients receiving 5-aza-2′-deoxycytidine (Decitabine)

Published:2016-12-01 Issue:4 Volume:176 Page:609-617
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Lübbert Michael¹,Ihorst Gabriele²,Sander Philipp N.¹,Bogatyreva Ljudmila¹³,Becker Heiko¹,Wijermans Pierre W.⁴,Suciu Stefan⁵,Bissé Emmanuel⁶,Claus Rainer¹

Affiliation:

1. Division of Haematology, Oncology and Stem Cell Transplantation; Faculty of Medicine; University of Freiburg; Freiburg Germany

2. Clinical Trials Unit; University of Freiburg Medical Centre; Freiburg Germany

3. Institute for Medical Biometry and Statistics; Faculty of Medicine and Medical Centre - University of Freiburg; Freiburg Germany

4. Department of Haematology; Haga Hospital; The Hague The Netherlands

5. EORTC Headquarters; Brussels Belgium

6. Institute for Laboratory Diagnostics; University of Freiburg; Freiburg Germany

Funder

California Department of Fish and Game

Wilhelm Sander-Stiftung

European Organisation for Research and Treatment of Cancer

Deutsche Krebshilfe

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14463/fullpdf

Reference29 articles.

1. Prognosis of older patients with acute myeloid leukemia receiving either induction or noncurative treatment: a single-center retrospective study;Behringer;Annals of Hematology,2003

2. Proposals for the classification of the acute leukaemias French-American-British (FAB) Co-operative Group;Bennett;British Journal of Haematology,1976

3. High-performance liquid chromatographic separation of human haemoglobins. Simultaneous quantitation of foetal and glycated haemoglobins;Bissé;Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences,1988

4. Report of an international working group to standardize response criteria for myelodysplastic syndromes;Cheson;Blood,2000

5. Revised Recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia;Cheson;Journal of Clinical Oncology,2003

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML;Clinical Epigenetics;2024-06-15

2. Foetal haemoglobin elevation, unfavourable prognosis, and protective role of genetic variants HBG2 rs7482144, HBS1L-MYB rs9399137 and BCL11A rs4671393 in children with ALL;Journal of Genetics;2024-04-17

3. Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML;2024-03-21

4. Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia;Experimental Hematology & Oncology;2024-02-20

5. Acquired haemoglobin F (HbF) in HbA1c analysis predating a diagnosis of myelodysplastic syndrome;Annals of Clinical Biochemistry: International Journal of Laboratory Medicine;2023-12-05